New affordable hepatitis C combination treatment shows 97 percent cure rate

The sofosbuvir/ravidasvir combination treatment for hepatitis C has been shown to be safe and effective, with extremely high cure rates, according to interim results from the Phase II/III STORM-C-1 trial.

This post was syndicated from Top Health News -- ScienceDaily. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply